Erasca (ERAS) EBITDA (2020 - 2026)

Erasca (ERAS) has 7 years of EBITDA data on file, last reported at -$187.9 million in Q1 2026.

• Quarterly EBITDA fell 427.4% year-over-year to -$187.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$293.2 million (down 66.24% YoY) and the FY2025 annual result came in at -$140.9 million, up 21.54% from the prior year.
• EBITDA slipped to -$187.9 million in Q1 2026, from -$32.6 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$32.6 million in Q4 2025 to a low of -$187.9 million in Q1 2026.
• A 5-year average of -$52.8 million and a median of -$36.5 million in 2022 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2023 — EBITDA jumped 75.47% — and 2026, when it plunged 427.4%.
• Tracing ERAS's EBITDA over 5 years: stood at -$138.1 million in 2022, then jumped by 75.47% to -$33.9 million in 2023, then fell by 5.43% to -$35.7 million in 2024, then increased by 8.7% to -$32.6 million in 2025, then plunged by 476.34% to -$187.9 million in 2026.
• The last three EBITDA figures came in at -$187.9 million (Q1 2026), -$32.6 million (Q4 2025), and -$34.5 million (Q3 2025), per Business Quant data.